Terray Therapeutics | 2018 | $201M | Small molecules |
---|---|---|---|
Insitro | 2018 | $643M | RNA |
Generate:Biomedicines | 2018 | $708M | Antibodies/proteins |
Genesis Therapeutics | 2019 | $327M | Small molecules |
Iambic Therapeutics | 2019 | $209M | Small molecules |
Inceptive | 2021 | $120M | RNA |
EvolutionaryScale | 2023 | $142M | Protein language models |
Xaira Therapeutics | 2023 | $1B | Antibodies/proteins |